British-Swedish pharmaceutical company along with the Oxford University have applied for a market approval of their COVID-19 vaccine in the EU, the European Medicines Agency (EMA) said in an announcement on Tuesday.
“EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University,” reads the statement by the Amsterdam-based company, which added that the assessment of the vaccine will proceed “under an acceler…
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
